AKTX logo

AKTX
Akari Therapeutics

8,616
Mkt Cap
$155.27M
Volume
229,484.00
52W High
$56.80
52W Low
$3.02
PE Ratio
-0.01
AKTX Fundamentals
Price
$5.14
Prev Close
$3.43
Open
$3.15
50D MA
$5.41
Beta
0.74
Avg. Volume
66,344.47
P/B
0.27
Rev/Employee
$0.00
$384.65
Loading...
Loading...
News
all
press releases
News Placeholder
The Biotech Repricing Wave May Be Starting as Capital Pours into High-Impact Oncology Platforms
Biotech investors are once again rotating aggressively into clinical-stage growth stories as a fresh wave of capital raises, pipeline expansions, analyst initiations, and oncology breakthroughs reshapes momentum across the sector. $NTHI, $IMMX, $RLAY, $AKTX, $LIMN
24-7 Market News·7h ago
News Placeholder
Why Akari Therapeutics Stock Is Surging On Thursday?
Akari Therapeutics PLC (NASDAQ:AKTX) sees stock growth fueled by Q1 2026 earnings optimism and a new European patent for its PH1 ADC payload.read more...
Benzinga·7d ago
<
...
1
>

Latest AKTX News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.